DrugPatentWatch Database Preview

Impax Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for IMPAX LABS INC, and when can generic versions of IMPAX LABS INC drugs launch?

IMPAX LABS INC has forty-nine approved drugs.

There are nine US patents protecting IMPAX LABS INC drugs. There is one tentative approval on IMPAX LABS INC drugs.

There are thirty-five patent family members on IMPAX LABS INC drugs in fourteen countries and twenty-two supplementary protection certificates in nine countries.

Summary for Impax Labs Inc

International Patents:	35
US Patents:	9
Tradenames:	43
Ingredients:	43
NDAs:	49

Drugs and US Patents for Impax Labs Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Impax Labs Inc	RYTARY	carbidopa; levodopa	CAPSULE, EXTENDED RELEASE;ORAL	203312-003	Jan 7, 2015		RX	Yes	No	8,454,998		Y
Impax Labs Inc	GLYBURIDE AND METFORMIN HYDROCHLORIDE	glyburide; metformin hydrochloride	TABLET;ORAL	076345-003	Feb 18, 2004	AB	RX	No	No
Impax Labs Inc	RYTARY	carbidopa; levodopa	CAPSULE, EXTENDED RELEASE;ORAL	203312-001	Jan 7, 2015		RX	Yes	No	9,901,640		Y
Impax Labs Inc	METHYLTESTOSTERONE	methyltestosterone	CAPSULE;ORAL	204851-001	Sep 21, 2015	AB	RX	No	No
Impax Labs Inc	PYRIDOSTIGMINE BROMIDE	pyridostigmine bromide	TABLET, EXTENDED RELEASE;ORAL	203184-001	Sep 15, 2015	AB	RX	No	No
Impax Labs Inc	RISEDRONATE SODIUM	risedronate sodium	TABLET, DELAYED RELEASE;ORAL	205066-001	Jun 29, 2018	AB	RX	No	No

Paragraph IV (Patent) Challenges for IMPAX LABS INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Extended-release Capsules	61.25 mg/245 mg		2015-06-10
	Extended-release Capsules	23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg		2015-06-24

International Patents for Impax Labs Inc Drugs

Country	Patent Number	Estimated Expiration
Japan	2015187178
South Korea	20100099731
Australia	2008343787
Taiwan	200706182
Mexico	2010007207
South Korea	101451564

Supplementary Protection Certificates for Impax Labs Inc Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2712622	122017000006	Germany		PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504
0809498	SPC/GB10/012	United Kingdom		PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
2712622	LUC00015	Luxembourg		PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101
0716606	6/2002	Austria		PRODUCT NAME: SEVELAMER SOWIE DESSEN PHARMAZEUTISCH VERTRAEGLICHEN SALZE; REGISTRATION NO/DATE: EU/1/99/123/001 - EU/1/99/123/004 20000128
0716606	SPC/GB02/011	United Kingdom		PRODUCT NAME: SEVELAMER; REGISTERED: UK EU/1/99/120/001-004 20000202
0613371	SPC/GB02/033	United Kingdom		PRODUCT NAME: FORMOTEROL (OPTIONALLY IN THE FORM OF THE FREE BASE OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE OF SUCH FREE BASE OR SALT ESPECIALLY AS FORMOTEROL FUMARATE DIHYDRATE) AND BUDESONIDE; REGISTERED: SE SE16047, 16048 20000825; UK PL17901/0091 20010515; UK PL17901/0092 20010515

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Impax
• Impax Labs
• Impax Labs Inc
• Impax Pharms